CIEMAT at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

CIEMAT brings 1 presentation to ISLB 2026 in Madrid, its home city. Its work covers how fluid samples are handled before testing and immune profiling in urothelial cancer. One study uses LEGENDplex multiplex immunoassays to track immune markers and treatment toxicity in urothelial cancer.

OrganizationISLB 2026 Attendance
CIEMAT
Madrid, Spain
ciemat.es
Universities & research institutes
Public research centre for energy, environment and technology whose biomedical units include a molecular oncology group.
Session
Sat Nov 7
4:00pm–5:30pm
Workshop Biological Fluids: Pre-analytical Issues
Pre-analytics
Poster
Part of Poster sessions
Application of LEGENDplex™ Multiplex Immunoassays for Immune Profiling and Toxicity Monitoring in Urothelial Cancer
New analytes · Clinical use
Collaborators: Hospital Universitario 12 de Octubre

Explore the full ISLB 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ISLB 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from CIEMAT

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction